This released a couple of days ago. The links provided below cover it pretty well. (not anytime soon but another potential….so, tired of "potentials" . But "potential" is much better than the alternative--no-potential.)
NIH Scientists Develop Promising Herpesvirus Drug Candidate (Jan 2013)
Blocks Infection and Reactivation in Mice
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and National Center for Advancing Translational Sciences, two components of the National Institutes of Health (NIH), have identified key proteins required by two different herpesviruses to initiate infection. Based upon these findings, the groups demonstrated that inhibiting the activities of these proteins with a novel drug blocks herpesvirus infection and reactivation from dormancy.
see the below links
http://www.niaid.nih.gov/topics/genitalHerpes/research/Pages/drugCandidate.aspx
http://www.eurekalert.org/multimedia/pub/51592.php (1 of 2)
http://www.eurekalert.org/multimedia/pub/51593.php (2 of 2)
http://stm.sciencemag.org/content/5/167.toc#ResearchArticles (SCROLL down to, "Infectious DiseaseTargeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency."
